CoChat

Drug-induced skin toxicity: gaps in preclinical testing cascade as opportunities for complex in vitro models and assays

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Abstract

Skin is the largest organ of the body and serves as the principle barrier to the environment. Composed of multiple cell types arranged in stratified layers with highly specialized appendages, it serves sensory and immune surveillance roles in addition to its primary mechanical function. Several complex in vitro models of skin (i.e. microphysiological systems (MPS) including but not limited to 3D tissues, organ-on-a-chip, organoids), have been developed and assays validated for regulatory purposes. As such, skin is arguably the most advanced organ with respect to model development and adoption across industries including chemical, cosmetic, and to a somewhat lesser extent, pharmaceutical. Early adoption of complex skin models and associated assays for assessment of irritation and corrosion spurred research into other areas such as sensitization, absorption, phototoxicity, and genotoxicity. Despite such considerable advancements, opportunities remain for immune capabilities, inclusion of appendages such as hair follicles, fluidics, and innervation, among others. Herein, we provide an overview of current complex skin model capabilities and limitations within the drug development scheme, and recommendations for future model development and assay qualification and/or validation with the intent to facilitate wider adoption of use within the pharmaceutical industry.

Overview

Integrity signals

Registry

Crossref · 10.1039/c9lc00519f

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 73 references

Research works printed but not linked: 17

  1. Abd, 2016, J. Clin. Pharmacol., 8, 163
  2. OECD , Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing , 2010
  3. G. F. Gerberick , J. A.Troutman , L. M.Foertsch and P. S.Kern , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 225–233
  4. A. Natsh , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 235–248
  5. E. Corsini and V.Galbiati , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 263–272
  6. T. Ramirez , A.Mehling and R.Landsiedel , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 249–262
  7. D. Keller , C.Bauch and P.Patel , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Spinger Cham , 2017 , pp. 377–391
  8. H. Sakaguchi and T.Ashikaga , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 289–309
  9. N. Alepee , C.Piroird and L.Nardelli , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Spinger Cham , 2017 , pp. 311–330
  10. M. Lindstedt , K. S.Zeller , H.Johansson and C.Borrebaeck , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 393–403
  11. N. Lambrechts , G.Schoeters , R.Van Den Heuvel , H.Witters , I.Nelissen and J.Hooyberghs , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 347–359
  12. P. R. Esser and S. F.Martin , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 449–454
  13. S. Pfuhler and K.Reisinger , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 513–525
  14. K. Reisinger and S.Pfuhler , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 527–539
  15. H. Kandarova and M.Liebsch , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 483–503
  16. H. Kojima , K.Hosoi and S.Onoue , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 477–482
  17. Coimbra, 2015, Ann. Transl. Med., 3, 76

Cited by

See all 55

Metadata

Authors
Hardwick, R. N., Betts, C. J., Whritenour, J., Sura, R., Thamsen, M., Kaufman, E. H., & Fabre, K.
Affiliations
  • Theravance Biopharma (United States) (US)
  • AstraZeneca (United Kingdom) (GB)
  • Pfizer (United States) (US)
  • AbbVie (United States) (US)
Corresponding author
Hardwick, Rhiannon N.
Venue
Lab on a Chip
Published
2020
Volume
20
Issue
2
Pages
199-214
ISSN
  • 1473-0189 (ISSN-L)
  • 1473-0197
OpenAlex
W2979806580
Cited by
48
References
73
Citations by year
2026: 4 · 2025: 8 · 2024: 7 · 2023: 10 · 2022: 5 · 2021: 10 · 2020: 4
FWCI
0.38
Type
journal article
Language
en
Open access
closed
Locations
  • Lab on a Chip (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
  • Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
Keywords
drug-induced skin toxicity, microphysiological systems, organ-on-a-chip, skin organoids, skin irritation, skin corrosion, skin sensitization, percutaneous absorption, phototoxicity, genotoxicity, hair follicle, innervation, drug development
MeSH terms
Drug Development, Animals, Drug Industry, Pharmaceutical Preparations, Humans, Models, Biological, Skin, Lab-On-A-Chip Devices

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.